Atlas Venture Life Science Advisors, LLC Portfolio Holdings
Atlas Venture Life Science Advisors, LLC
- $455 Million
- Q2 2025
Atlas Venture Life Science Advisors, LLC has filed its 13F form on August 12, 2025 for Q2 2025 where it was disclosed a total value porftolio of $455 Million distributed in 11 stocks.
Among their holdings, we can observe that their the top five positions include companies like: Kymera Therapeutics, Inc. with a value of $214M, Dyne Therapeutics, Inc. with a value of $86.9M, Third Harmonic Bio, Inc. with a value of $56.5M, Vigil Neuroscience, Inc. with a value of $46.4M, and Day One Biopharmaceuticals, Inc. with a value of $41.8M.
Examining the 13F form we can see an increase of $113M in the current position value, from $341M to 455M.
Below you can find more details about Atlas Venture Life Science Advisors, LLC portfolio as well as his latest detailed transactions.